Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy
Immunity, Inflammation and Disease · 2023-10 · 11 (10)
DOI: 10.1002/iid3.1041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 11.10.2023. Verfasst von Fen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan City, Shanxi Province, China. Hauptthemen laut MEDLINE: Antirheumatic Agents, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate the clinical efficacy of plasma exchange (PE) with or without prednisone and hydroxychloroquine (HCQ) for the treatment of systemic lupus erythematosus (SLE) during pregnancy.
Methods
The clinical characteristics of 14 pregnant women with SLE admitted to our hospital were retrospectively analyzed, including 7 only treated with prednisone and HCQ (non‐PE group) as well as 7 combined PE (PE group). The delivery situations of 14 patients were recorded. Data like erythrocyte sedimentation rate (ESR), urine protein, platelet count, and SLEDAI scores were compared between two groups before treatment and 3, 6, and 12 months after delivery.
Results
Three patients in the non‐PE group ended in miscarriage while all patients in the PE group were delivered successfully. Eleven successfully delivered fetuses in the two groups were healthy, and the Apgar scores were over 8. The ESR of the PE group was significantly lower than that of the non‐PE group at 6 and 12 months after delivery, while there was no statistical difference in ESR between the two groups before treatment and 3 months after delivery. The ESR and urine protein were significantly higher in the non‐PE group at months 3, 6, and 12 postpartum. There was a significant decrease in disease activity postpartum in the PE group compared to predelivery disease activity. The change in platelet counts between the two groups significantly increased over time in the PE group, while SLEDAI scores decreased.
Conclusions
The combination of PE and oral prednisone and HCQ is possibly a more effective treatment than oral prednisone and HCQ alone for patients with active SLE during pregnancy. This treatment option reduces pregnancy loss and promotes the patients' postpartum condition to a certain extent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan City, Shanxi Province, China.
- Department of Respiratory Medicine, Xinzhou People's Hospital, Xinzhou City, Shanxi Province, China.
- State Key Laboratory of Multiphase Flow in Power Engineering, Xi'an Jiaotong University, Xi'an, Shanxi Province, China.
ORCID-Profile: Fen Zhang, Jun-Wei Chen
Zitieren
APA
Zhang, F., Zhang, B. Y., Fan, R., Cheng, T., Hu, X. R., Liu, Y. Q., Cen, X., Bu, Y. J., Cao, J. P., Chen, F. W., & Chen, J. W. (2023). Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy. Immunity, Inflammation and Disease, 11(10). https://doi.org/10.1002/iid3.1041
Vancouver
Zhang F, Zhang BY, Fan R, Cheng T, Hu XR, Liu YQ, et al. Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy. Immunity, Inflammation and Disease. 2023;11(10). doi:10.1002/iid3.1041
BibTeX
@article{Zhang2023,
author = {Zhang, Fen and Zhang, Bing-Ying and Fan, Ru and Cheng, Ting and Hu, Xiao-Rong and Liu, Yu-Qing and Cen, Xing and Bu, Yu-Jie and Cao, Jian-Ping and Chen, Feng-Wu and Chen, Jun-Wei},
title = {Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy},
journal = {Immunity, Inflammation and Disease},
year = {2023},
volume = {11},
number = {10},
doi = {10.1002/iid3.1041}
}
EUVIMED